262601-94-5 → HCID 21936681, compound
Reaction equation
[N:1]1[CH:6]=[CH:5][CH:4]=[CH:3][C:2]=1[CH:7]=[C:8]1[S:12][C:11](=[O:13])[NH:10][C:9]1=[O:14]>O1CCCC1.[Pd]>[N:1]1[CH:6]=[CH:5][CH:4]=[CH:3][C:2]=1[CH2:7][CH:8]1[S:12][C:11](=[O:13])[NH:10][C:9]1=[O:14]Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 5-pyridin-2-ylmethylene-thiazolidine-2,4-dione (5.0 g, 0.024 mol, prepared in a similar way as described in J. Med. Chem. 41 (10), 1619–1630 (1998)) in tetrahydrofuran (300 ml) was added 10% palladium on carbon (1 g) and the resulting mixture was hydrogenated. After 50 ml of hydrogen was consumed and additional portion of 10% palladium on carbon (5 g) was added and the hydrogenation was continued at 50 psi for 16 h. The mixture was filtered and the filtrate evaporated in vacuo. The residue was subjected to flash column chromatography (1 l silicagel) using a mixture of ethyl acetate/hexane, (1:1) as eluant. Semi pure fractions were collected and the solvent evaporated in vacuo affording 0.8 g (16,%) of 5-pyridin-2-ylmethyl-thiazolidine-2,4-dione as a solid.
Workup
- customAfter 50 ml of hydrogen was consumed
- additionadditional portion of 10% palladium on carbon (5 g) was added
- filtrationThe mixture was filtered
- customthe filtrate evaporated in vacuo
- additiona mixture of ethyl acetate/hexane, (1:1) as eluant
- customSemi pure fractions were collected
- customthe solvent evaporated in vacuo
Sources & evidence
- ORD record
- ord-3e7014a09de54f0299b2d43cb1428acf
- Source dataset
- uspto-grants-2006_10
- Patent number
- US07115624B1
Reaction notes
Loading…